EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BST2 Drives Epithelial Ovarian Cancer Progression via Macrophage M2 Polarization, Neural Remodeling, and Immunosuppressive Microenvironment Formation

Limin Zhang iD, Xiaoli Huang, Shaoyu Wang, Shaozhan Chen, Jinhua Wang iD, Lihong Chen iD, Pengming Sun iD

Human Mutation · 2025

DOI: 10.1155/humu/8719836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, 2025. Verfasst von Limin Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Carcinoma, Ovarian Epithelial, Tumor Microenvironment, Macrophages, Ovarian Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epithelial ovarian cancer (EOC) ranks as the most lethal of gynecological cancers. Despite advances in therapeutic interventions that have marginally extended survival rates, the early detection and management of EOC pose significant hurdles. Consequently, identifying novel therapeutic targets is imperative for enhancing the survival outcomes of patients afflicted with this malignancy.

Purpose

This research is aimed at exploring the functions of Bone Marrow Stromal Antigen 2 (BST2) in the pathogenesis of EOC and their influence on macrophage polarization, evaluating their viability as targets for immunotherapy.

Methods

Gene expression profiles and clinical data of EOC patients were retrieved from the TCGA repository to develop prognostic models centered on BST2. The expression patterns of BST2 in HGSOC cell lines were quantified via RT‐qPCR and Western blot analyses. The impact of BST2 on the proliferative, migratory, and invasive capacities of EOC cells was assessed through gene silencing and gene overexpression experiments.

Results

Elevated levels of BST2 expression were observed in EOC tissues, correlating with adverse prognostic indicators. Enhanced BST2 expression facilitated EOC cell growth, motility, and invasiveness, whereas BST2 suppression mitigated these oncogenic attributes. In vivo assessments revealed that BST2 augmentation modified the macrophage phenotypes within grafted ovarian tumors, with BST2 diminution reversing these effects.

Conclusion

The findings propose that BST2 acts as a pivotal facilitator in the progression of ovarian carcinoma. The expression metrics of BST2 may serve as prognostic markers for patient outcomes in EOC. These findings suggest that BST2 is a key promoter of ovarian cancer progression, and its expression may serve as a prognostic marker. The mechanisms uncovered, including the modulation of macrophage polarization and neural marker expression, indicate that targeting BST2 represents a potential future strategy for immunotherapy in EOC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Ovarian EpithelialTumor MicroenvironmentMacrophagesOvarian NeoplasmsGPI-Linked ProteinsAntigens, CDHumansFemaleCell Line, TumorDisease ProgressionAnimalsGene Expression Regulation, NeoplasticMicePrognosisCell ProliferationCell MovementBiomarkers, TumorBone Marrow Stromal Antigen 2

Stichwörter der Autor:innen

BST2epithelial ovarian cancermacrophagesneurons

Substanzen

BST2 protein, humanGPI-Linked ProteinsAntigens, CDBiomarkers, TumorBone Marrow Stromal Antigen 2

Autor:innen und Institutionen

  • College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, China.
  • Department of Obstetrics and Gynecology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.
  • Department of Obstetrics and Gynecology, National Regional Medical Center, Binhai Campus of The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.
  • Laboratory of Gynecologic Oncology, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Maternity and Child Health Hospital, Fujian medical University, Fuzhou, Fujian, China.
  • Fujian Clinical Research Center for Gynecologic Oncology, Fujian Maternity and Child health Hospital (Fujian Obstetrics and Gynecology Hospital), Fuzhou, Fujian, China.

ORCID-Profile: Limin Zhang, Jinhua Wang, Lihong Chen, Pengming Sun

Zitieren

APA

Zhang, L., Huang, X., Wang, S., Chen, S., Wang, J., Chen, L., & Sun, P. (2025). BST2 Drives Epithelial Ovarian Cancer Progression via Macrophage M2 Polarization, Neural Remodeling, and Immunosuppressive Microenvironment Formation. Human Mutation. https://doi.org/10.1155/humu/8719836

Vancouver

Zhang L, Huang X, Wang S, Chen S, Wang J, Chen L, et al. BST2 Drives Epithelial Ovarian Cancer Progression via Macrophage M2 Polarization, Neural Remodeling, and Immunosuppressive Microenvironment Formation. Human Mutation. 2025. doi:10.1155/humu/8719836

BibTeX
@article{Zhang2025,
  author = {Zhang, Limin and Huang, Xiaoli and Wang, Shaoyu and Chen, Shaozhan and Wang, Jinhua and Chen, Lihong and Sun, Pengming},
  title = {BST2 Drives Epithelial Ovarian Cancer Progression via Macrophage M2 Polarization, Neural Remodeling, and Immunosuppressive Microenvironment Formation},
  journal = {Human Mutation},
  year = {2025},
  doi = {10.1155/humu/8719836}
}
Kostenlos starten →